Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model. Read more about Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model.
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival. Read more about Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.
Level I and II deficits-A clinical survey on international practice of awake craniotomy and definitions of postoperative "major" and "minor" deficits. Read more about Level I and II deficits-A clinical survey on international practice of awake craniotomy and definitions of postoperative "major" and "minor" deficits.
Oligodendroglioma patient survival is associated with circulating B-cells and age. Read more about Oligodendroglioma patient survival is associated with circulating B-cells and age.
BSBM-03 TARGETABLE GENE EXPRESSION CHANGES MEDIATE EXTRAVASATION OF BREAST CANCER CELLS FROM THE CIRCULATION AND LOCAL PROLIFERATION IN THE BRAIN. Read more about BSBM-03 TARGETABLE GENE EXPRESSION CHANGES MEDIATE EXTRAVASATION OF BREAST CANCER CELLS FROM THE CIRCULATION AND LOCAL PROLIFERATION IN THE BRAIN.
Marrow-ablative consolidation chemotherapy and molecular targeted therapy delivered in a risk-adapted manner for newly diagnosed children with choroid plexus carcinoma: A work in progress. Read more about Marrow-ablative consolidation chemotherapy and molecular targeted therapy delivered in a risk-adapted manner for newly diagnosed children with choroid plexus carcinoma: A work in progress.
Response to immune checkpoint inhibition in a meningioma with DNA mismatch repair deficiency. Read more about Response to immune checkpoint inhibition in a meningioma with DNA mismatch repair deficiency.
Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward. Read more about Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward.
Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized 13C magnetic resonance spectroscopy approaches. Read more about Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized 13C magnetic resonance spectroscopy approaches.
Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect. Read more about Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect.
